| Company Name | Exchange | Ticker | Last Price | Day 1 (% Change) | Day 2 (% Change) | 52 WEEK HIGH | 52 WEEK LOW | Last Volume | M.Cap MM ($) |
| GlycoMimetics Inc | NASDAQ | GLYC | 8.38 | 7.1% | 20.4% | 18.99 | 6.12 | 222,700 | 157.5 |
| Isis Pharmaceuticals Inc | NASDAQ | ISIS | 30.37 | 11.5% | 9.2% | 62.66 | 20.41 | 5,232,806 | 3,570.8 |
These two U.S. stocks are featured as top stocks of the day based on their price performance during previous trading sessions. These stocks recorded a strong price gain momentum during the past two trading session with significant volumes.
GlycoMimetics Inc (NASDAQ: GLYC), a clinical-stage biotechnology company focused on the discovery and development of glycomimetic drugs to address medical needs, gained more than 29% during its past two trading sessions gaining more than 7% in each of the two consecutive days. During its last trading session, the stock surged 20.4% closing at $8.38 with significant trading volumes of 222,700 shares. During its past 5-trading sessions, GLYC surged 24.8% with 5-day average volume of 204,345 shares compared to 1-month daily average volume of 91,927 shares.
Isis Pharmaceuticals Inc (NASDAQ: ISIS), engaged in developing therapeutic drugs inhibiting cell protein synthesis, gained more than 22% during its past two trading sessions gaining more than 9% in each of the two consecutive days. During its last trading session, the stock surged 9.2% closing at $30.37 with significant trading volumes of 5.23 million shares. During its past 5-trading sessions, ISIS surged 22.7% with 5-day average volume of 3.7 million shares compared to 1-month daily average volume of 3.1 million shares.
